In:
International Journal of Cancer, Wiley, Vol. 148, No. 3 ( 2021-02), p. 692-701
Abstract:
What's new? Tumor metastasis is still the main cause of breast cancer mortality. Treatment of metastatic tumors is often based on the hormone receptor and human epidermal growth factor receptor 2 status of the primary tumor. However, as many as a third of patients with metastases have altered receptor status. Does this receptor conversion affect prognosis? In this large Chinese study, the authors found that, in many cases, the answer is yes. These results indicate that it is clinically important to biopsy distant metastases and assess receptor status whenever possible and to use these results to guide treatment.
Type of Medium:
Online Resource
ISSN:
0020-7136
,
1097-0215
Language:
English
Publisher:
Wiley
Publication Date:
2021
detail.hit.zdb_id:
218257-9
detail.hit.zdb_id:
1474822-8